29 Apr

Why AI is making data an essential part of IP strategy

From diagnosis support to biological engineering, AI has the potential to reshape the entire pharmaceutical industry. Gareth Jones at BenevolentAI provides a number of tips on how IP professionals can adapt their strategies as data becomes key to revenue earn

Gareth Jones

Vice president of intellectual property | BenevolentAI